bioRxivNeurosciencePreprint
An Early Olfactory Transcriptomic Signature of Tauopathy: Gbp2b Emerges as a Candidate Biomarker of Tau-Driven Neuroinflammation
Marion DourteiD, Ayeh Bouloki, Marc DieuiD, Malika Magomadov, Esther Paître, Núria SuelvesiD, Patricia RenardiD, Pascal Kienlen‐CampardiD
Abstract
Olfactory dysfunction is increasingly recognized as an early feature of neurodegenerative diseases such as Alzheimers disease. PS19 mice, a well-established tauopathy model, exhibit hallmarks of tau pathology--including hyperphosphorylated tau and pretangle formations--in various regions of the olfactory system. Notably, very recent data demonstrated that aberrantly hyperphosphorylated tau (pTau) was detected as early as 1.5 months of age in the olfactory epithelium (OE). This region contains olfactory sensory neurons projecting to the olfactory bulb (OB), where similar pTau pattern was also observed at this early stage. By 6 months, tau pretangles were evidenced in higher olfactory areas such as the piriform and entorhinal cortices. Given the early involvement of the OE and OB in tau pathology, we performed transcriptomic analyses at 3, 6, and 9 months to investigate the molecular pathways underlying tau pathology in these olfactory regions. Due to the OEs peripheral location and anatomical accessibility, we also aimed in that respect to identify potential early biomarkers of tauopathy. The hippocampus, a key brain region affected in Alzheimers disease and related disorders, was included in the analysis as a comparative reference due to its known vulnerability and clinical relevance. Our analyses revealed region- and age-specific gene expression changes in PS19 mice. Functional enrichment analyses indicated a temporal progression of molecular alterations associated with tau pathology. We identified a subset of genes differentially expressed across different time points and/or regions. Among these, Gbp2b emerged as a particularly promising early biomarker candidate for tauopathy in the OE, showing consistent upregulation across tau pathological stages and brain regions. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=152 SRC="FIGDIR/small/662324v1_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@17148c1org.highwire.dtl.DTLVardef@5fa7dborg.highwire.dtl.DTLVardef@51e21org.highwire.dtl.DTLVardef@1fd4302_HPS_FORMAT_FIGEXP M_FIG Created in BioRender. Kienlen-Campard, P. (2025) https://BioRender.com/k7xoypd C_FIG
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: benchmarking
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Olfactory Epithelium: A Critical Gateway for Pathological Tau Propagation and a Target for Mitigating Tauopathy in the Central Nervous System
Marion Dourte, Esther Paître, … Pascal Kienlen‐Campard·Acta NeuropathologicaPeer-reviewed·Jun 19, 2025
- Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies
Marco Antônio De Bastiani, Bruna Bellaver, … the Alzheimer’s Disease Neuroimaging Initiative·Brain, Behavior, and ImmunityPeer-reviewed·May 1, 2023
- Integration of transcriptional signatures from brain tissue and plasma extracellular vesicles of a preclinical tauopathy mouse model
Tanzima Tarannum Lucy, A. N. M. Mamun-Or-Rashid, … Nicholas Francis Fitz·International Journal of Molecular SciencesPeer-reviewed·Jun 3, 2026
- Visual evoked potentials as an early-stage biomarker in the rTg4510 tauopathy mouse model
Aleksandra Parka, Christiane Volbracht, … Florence Sotty·Journal of Alzheimer s DiseasePeer-reviewed·Mar 31, 2023
- Tau pathology in the dorsal raphe may be a prodromal indicator of Alzheimer's disease
Samantha R. Pierson, Kimberly L. Fiock, … Catherine Anne Marcinkiewcz·Molecular PsychiatryPeer-reviewed·Aug 14, 2024
- Differential neural circuit vulnerability to β-amyloid and tau pathologies in novel Alzheimer disease mice
Maria Dolores Capilla-López, Ángel Deprada-Fernandez, … Carlos A. Saura·Molecular PsychiatryPeer-reviewed·Jan 30, 2025